Cramer’s lightning round: Nokia is ‘the definition of dead money’

Cramer’s lightning round: Nokia is ‘the definition of dead money’


Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.

Cleveland-Cliffs: “If we’re going to do steels, I like Cleveland-Cliffs very cheap, but Nucor is almost has cheap, and it’s got a much better record and is a cleaner steel producer. That’s what we want right now.”

Enbridge: “I think that is a great stock. I am tempted to add it to the bullpen for …. the Investing Club.”

HighPeak Energy: “Oh my god, at $22, I mean come on. [Buy, buy, buy].”

Marathon Oil: “No, we went over that this morning on our ‘Morning Meeting’ that’s part of the CNBC Investing Club at 10:20 [a.m. ET.]. We continue to like Devon here. We think Devon goes higher. That’s the horse to bet on.”

Standard Lithium: “No, no. That’s a Canadian company that don’t make any money. We got to stick with money-making companies. How about Tesla? They’re also in the lithium business.”

Watsco: “I have not looked at Watsco recently enough. I did love it because my friend Matt Horween, writing partner, introduced it to me. Three percent yield, doing incredibly well. But we’re going to double down on the homework on Watsco.”

Nokia: “That is just the definition of dead money, and I’m done with that. We’re going to try to make money with our money, not do nothing with our money. I want that reinvested in some of the things we like for the Investing Club.”

Rocket Lab USA: “[Sell, sell, sell]. We only like to invest in companies that make money.”

Carnival Corp.: Does not recommend

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.



Source

Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More
Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices
Business

Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices

A customer shops for Halloween candy at a Walmart Supercenter on October 16, 2024 in Austin, Texas.  Brandon Bell | Getty Images The scariest thing haunting Halloween this year isn’t a ghost, goblin or ghoul — it’s the price of chocolate. From Snickers to Reese’s to Twix, one of America’s favorite indulgences is getting more […]

Read More